On-Demand Webcast

Global Perspective on BRCA Mutations, PARPi, and Biomarker-Driven Strategies in Pancreatic Cancer

Get up to date with international insights on assessing and targeting BRCA1/2 and other DNA damage repair gene alterations in pancreatic cancer with downloadable slides and on-demand Webcast from a live Webinar plus an expert commentary.

Dirk Arnold, MD, PhD

Michael J. Pishvaian, MD, PhD

On-Demand Webcast

Hear from global experts in this on-demand Webcast capturing a live CCO Webinar focused on leveraging PARP inhibitors and chemotherapy for optimal treatment of pancreatic cancer with BRCA1/2 and other DNA damage repair gene alterations.

Dirk Arnold, MD, PhD

Michael J. Pishvaian, MD, PhD Released: October 8, 2020

Molecular Testing Considerations for Patients With Pancreatic Cancer

Treatment of Patients With BRCA Mutated Pancreatic Cancer: The Clinical Perspective

Global Perspective on BRCA Mutations, PARPi, and Biomarker-Driven Strategies in Pancreatic Cancer

Global Perspective on BRCA Mutations, PARPi, and Biomarker-Driven Strategies in Pancreatic Cancer

Global Perspective on BRCA Mutations, PARPi, and Biomarker-Driven Strategies in Pancreatic Cancer

On-Demand Webcast

Global Perspective on BRCA Mutations, PARPi, and Biomarker-Driven Strategies in Pancreatic Cancer

Leaving the CCO site